Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Comparison Table: Subcutaneous vs Intramuscular Kisspeptin Administration

The distinction between subcutaneous and intramuscular injection routes affects peptide pharmacokinetics significantly. Here's how administration depth changes absorption characteristics and practical administration considerations. Subcutaneous (subq) 4–6mm in

This comparison does not assign a generated winner or score.

  • The distinction between subcutaneous and intramuscular injection routes affects peptide pharmacokinetics significantly. Here's how administration depth changes absorption characteristics and practical administration considerations.
  • Subcutaneous (subq)
  • 4–6mm into fat layer
  • 45° with tissue pinch
  • Gradual, sustained release
  • 60–90 minutes
  • Low if sites rotated
  • Yes. Standard protocol
  • Intramuscular (IM)
  • 15–25mm into muscle
  • 90° without pinch
  • Faster initial uptake
  • 30–45 minutes
  • Moderate (soreness common)
  • No. Creates erratic peaks
  • Intradermal (ID)
  • 1–2mm into dermis
  • 10–15° bevel-up
  • Very slow diffusion
  • 120+ minutes
  • High (visible wheal forms)
  • No. Not studied for peptides
  • Intravenous (IV)
  • Direct vascular access
  • N/A (catheter)
  • Immediate
  • 5–10 minutes
  • High (requires sterile technique)
  • No. Research setting only